2017, Number 4
<< Back Next >>
Ann Hepatol 2017; 16 (4)
The Role of TIPS in Patients with Refractory Ascites and Portal Vein Thrombosis
Chinchilla-López P, Hamdan-Pérez N, Guerrero-Ixtlahuac J, Barranco-Fragoso B, Méndez-Sánchez N
Language: English
References: 5
Page: 619-620
PDF size: 246.06 Kb.
ABSTRACT
Nowadays the contraindication for transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal vein thrombosis (PVT)
had been modify. The experience and technology have reduce the complications for this procedure. We report a case of refractory
ascites and portal vein thrombosis to emphasize the role of TIPS in the treatment for this condition.
REFERENCES
Manzano-Robleda M del C, Barranco-Fragoso B, Uribe M, Méndez-Sánchez N. Portal vein thrombosis: what is new? Ann Hepatol 2015; 1: 20-7.
Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R, De Nucci C, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002; 34: 535-8.
Chinchilla-López P, Baptista-González H, Intagliata NM, Northup PG, Caldwell SH, Méndez-Sánchez N. The direct oral anticoagulants in patients with and without liver disease. AME Med J 2017; 2: 44.
Kumar A, Kaufman Ch. TIPS performed in a patient with complete portal vein thrombosis. Radiol Case Rep 2017; 2: 327-30.
Lucaa A, Miraglia R, Caruso S. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011; 6: 846-52.
Full text